UMOD
UMOD (uromodulin) is the most abundant protein in mammalian urine under physiological conditions, where it helps defend the urinary tract and limits salt crystal formation. It was formerly known as uromucoid or Tamm-Horsfall glycoprotein. Browse Assay Genie's current range of UMOD research reagents below, or read on for the biology behind the target.
UMOD encodes uromodulin, a glycoprotein that works mainly in the urine. It may contribute to colloid osmotic pressure, retard the passage of positively charged electrolytes, and inhibit the formation of liquid containing supersaturated salts, and so the formation of salt crystals. The NCBI Gene summary likewise describes it as a probable constitutive inhibitor of calcium crystallisation in renal fluids.
Uromodulin also protects against urinary tract infection. It binds type 1 fimbriated E. coli through the bacterial adhesin fimH, which mediates the stable formation of bacterial aggregates. This prevents the bacteria from binding to uroplakins UPK1A and UPK1B, the urothelial receptors for type 1 fimbriae, and allows pathogen clearance through micturition. Uromodulin also promotes aggregation of K. pneumoniae, P. aeruginosa and S. mitis, so it may protect against other uropathogens too.
The protein is found at the apical and basolateral cell membrane, in the cilium membrane and in secreted form. Urinary uromodulin is released by proteolytic cleavage of the ectodomain of a glycosyl phosphatidylinositol-anchored form on the luminal cell surface of the loop of Henle. Defects in the UMOD gene are associated with the renal disorders medullary cystic kidney disease-2, glomerulocystic kidney disease with hyperuricaemia and isosthenuria, and familial juvenile hyperuricaemic nephropathy. Alternative splicing produces multiple transcript variants. Mouse and rat both carry a Umod ortholog.
Defects in UMOD are associated with medullary cystic kidney disease-2, glomerulocystic kidney disease with hyperuricaemia and isosthenuria, and familial juvenile hyperuricaemic nephropathy.
Uromodulin binds fimH on type 1 fimbriated E. coli, blocks uroplakin binding and supports pathogen clearance through micturition.
Uromodulin may inhibit calcium crystallisation and the formation of salt crystals from supersaturated urinary fluids.
As the most abundant protein in mammalian urine, uromodulin is released from a GPI-anchored form on the loop of Henle.
In urine, uromodulin may contribute to colloid osmotic pressure, retard positively charged electrolytes and inhibit salt crystal formation. It also binds type 1 fimbriated E. coli through fimH, preventing uroplakin binding and allowing clearance through micturition. Check the datasheet of any product for its validated reactivity.
UMOD is the HGNC symbol for uromodulin, previously called uromucoid or Tamm-Horsfall glycoprotein. The gene produces multiple transcript variants through alternative splicing. Urinary uromodulin is released from a GPI-anchored form by proteolytic cleavage of its ectodomain.
Defects in UMOD are associated with medullary cystic kidney disease-2, glomerulocystic kidney disease with hyperuricaemia and isosthenuria, and familial juvenile hyperuricaemic nephropathy. Mouse and rat have a Umod ortholog, so the gene is conserved in common rodent models.
Other urinary and renal proteins with research products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P07911; product specifications from Assay Genie datasheets.